Friday, the European Medicines Agency (EMA), the European Union's (EU) official health regulator approved the use of the Moderna COVID-19 vaccine for people aged 12 to 17 years, becoming the second vaccine allowed for use in adolescents in the 27 European Union countries.

The EMA said in a statement that the concerned committee recommended the use of the vaccine for the aforementioned age group, noting that it will be administered in two doses separated by four weeks.